Article

Healthcare Consumers’ Perceptions of Incentive-Linked Prescribing: A Scoping Review of Research

2024-02-28

Abstract excerpt

Incentive-linked prescribing (ILP) is considered a controversial practice universally. If incentivised, physicians may prioritise meeting pharmaceutical sales targets through prescriptions, rather than considering patients’ health and wellbeing. Despite the potential harms of ILP to patients and important stakeholders in the healthcare system, healthcare consumers (HCCs) which include patients and the general publ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 30607e02-aa47-542b-8c48-7bffb94d1f12
DOI: 10.1101/2024.02.27.24303447

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Healthcare Consumers’ Perceptions of Incentive-Linked Prescribing: A Scoping Review of ResearchDOI 10.1101/2024.02.27.24303447Read

Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey dataSemantic proximity Read

Awareness and perceptions among members of a Japanese cancer patient advocacy group concerning the financial relationships between the pharmaceutical industry and physicians: a mixed-methods analysis of survey dataSemantic proximity Read

Prescribing Variation in General Practices in England Following a Direct Healthcare Professional Communication on MirabegronSemantic proximity Read

Addressing low-value pharmacological prescribing in primary prevention of CVD through a structured evidence-based and theory-informed process for the design and testing of de-implementation strategies: the DE-imFAR studySemantic proximity Read

Patient request amplifies other determinants of providing low value care: A factorial survey experiment in physicians’ decision-makingSemantic proximity Read

Re-Thinking 'Product Claim' DTCA in the United States: Implications for Regulation and Public HealthSemantic proximity Read

The current status, dilemmas and recommendations regarding clinical pharmacists' participation in inpatient pharmaceutical care under the pharmaceutical care fee policy — a qualitative studySemantic proximity Read

Resetting priorities in precision medicine: the role of social prescribing.Semantic proximity Read

The Effect of Three Key Administrative Errors on Patient Trust in Physicians: Prescription Errors, Confidentiality Breaches, and Appointment ErrorsSemantic proximity Read

The CMO System Model: A Dynamic Framework to Operationalize Adaptive Pharmaceutical Care and Drive Health-System SustainabilitySemantic proximity Read

Evaluating the impact of financial incentives on inequalities in smoking cessation in primary careSemantic proximity Read

Use of Research Evidence Varied in Efforts to Expand Pharmacist Prescriptive Authority: Recommendations to Increase Research UtilizationSemantic proximity Read